OKYO Pharma Ltd — Investor Relations & Filings
Filings indexed
274
across all filing types
Latest filing
2026-05-19
Regulatory Filings
Country
US
United States of America
Listing
US
OKYO
OKYO Pharma Ltd. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics for inflammatory eye diseases and chronic pain. The company's primary focus is on addressing significant unmet medical needs in neuropathic corneal pain (NCP) and dry eye disease (DED). Its lead product candidate, Urcosimod (OK-101), is a novel G protein-coupled receptor (GPCR) agonist that targets the chemerin receptor to produce anti-inflammatory and pain-reducing effects. OKYO is the first company to receive Investigational New Drug (IND) clearance from the FDA to clinically evaluate a drug specifically for NCP, a condition with no approved treatments. Urcosimod has also been granted Fast Track Designation by the FDA for the treatment of NCP.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K | 2026-05-19 | English | |
| 6-K - OKYO Pharma Ltd (0001849296) (Filer) | 2026-04-29 | English | |
| 6-K - OKYO Pharma Ltd (0001849296) (Filer) | 2026-04-07 | English | |
| 6-K - OKYO Pharma Ltd (0001849296) (Filer) | 2026-03-19 | English | |
| 6-K - OKYO Pharma Ltd (0001849296) (Filer) | 2026-03-19 | English | |
| 6-K - OKYO Pharma Ltd (0001849296) (Filer) | 2026-03-19 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46533603 | 6-K | 2026-05-19 | English | ||
| 38521528 | 6-K - OKYO Pharma Ltd (0001849296) (Filer) | 2026-04-29 | English | ||
| 33702451 | 6-K - OKYO Pharma Ltd (0001849296) (Filer) | 2026-04-07 | English | ||
| 32987625 | 6-K - OKYO Pharma Ltd (0001849296) (Filer) | 2026-03-19 | English | ||
| 32986882 | 6-K - OKYO Pharma Ltd (0001849296) (Filer) | 2026-03-19 | English | ||
| 32985472 | 6-K - OKYO Pharma Ltd (0001849296) (Filer) | 2026-03-19 | English | ||
| 32981230 | 3 - OKYO Pharma Ltd (0001849296) (Issuer) | 2026-03-19 | English | ||
| 32981223 | 3 - OKYO Pharma Ltd (0001849296) (Issuer) | 2026-03-19 | English | ||
| 32975253 | 6-K - OKYO Pharma Ltd (0001849296) (Filer) | 2026-03-18 | English | ||
| 32057238 | SCHEDULE 13G Filing | 2026-02-18 | English | ||
| 32057239 | 424B5 Filing | 2026-02-17 | English | ||
| 32057542 | 6-K Filing | 2026-02-13 | English | ||
| 32057191 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 32057237 | 424B5 Filing | 2026-02-12 | English | ||
| 32057213 | 6-K Filing | 2026-02-11 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
China Animal Husbandry Industry Co.,Ltd.
Produces animal health products, vaccines, veterinary drugs…
|
600195 | CN | Manufacturing |
|
China Isotope & Radiation Corporation
Develops and distributes radioisotope and radiation technol…
|
1763 | HK | Manufacturing |
|
China Medical System Holdings Limited
Innovation-driven specialty pharmaceutical group engaged in…
|
867 | KY | Manufacturing |
|
China NT Pharma Group Company Limited
Engaged in biotech R&D, manufacturing, sales, and marketing…
|
1011 | HK | Manufacturing |
|
CHINA PHARMA HOLDINGS, INC.
Develops, manufactures, and markets prescription, OTC, and …
|
CPHI | US | Manufacturing |
|
China Regenerative Medicine International Limited
Develops, produces, and sells tissue engineering and regene…
|
8158 | HK | Manufacturing |
|
China Resources Boya Bio-pharmaceutical Group Co., Ltd
Researches and produces blood products and plasma-derived m…
|
300294 | CN | Manufacturing |
|
China Resources Double-Crane Pharmaceutical Co.,Ltd.
Develops and manufactures chronic disease medications and p…
|
600062 | CN | Manufacturing |
|
CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO.,LTD
Develops and produces OTC medicines, TCM, and supplements f…
|
600750 | CN | Manufacturing |
|
China Resources Pharmaceutical Group Limited
Integrated pharmaceutical value chain encompassing R&D, man…
|
3320 | HK | Manufacturing |
OKYO Pharma Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34361/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34361 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34361 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34361 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34361}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OKYO Pharma Ltd (id: 34361)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.